Search Medical Condition
Please enter condition
Please choose location

Garner, North Carolina Clinical Trials

A listing of Garner, North Carolina clinical trials actively recruiting patient volunteers.

RESULTS

Found (147) clinical trials

Safety and Efficacy of KPI-12 in Subjects With Dry Eye Disease

This is a Phase 3, multi-center, double-masked, randomized, vehicle-controlled, parallel-group study designed to evaluate the safety and efficacy of KPI-121 0.25% ophthalmic suspension versus vehicle in subjects with dry eye disease.

Phase

3.77 miles

Learn More »

Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo

The purpose of this study is to determine if an investigational treatment is effective compared with placebo and PVP-Iodine in the treatment of adults and children with adenoviral conjunctivitis.

Phase

3.77 miles

Learn More »

Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo

The purpose of this study is to determine if an investigational treatment is effective compared with placebo and PVP-Iodine in the treatment of adults and children with bacterial conjunctivitis.

Phase

3.77 miles

Learn More »

Do You Experience Heavy Menstrual Bleeding and Pain? Wake Research Associates is enrolling volunteers in a research study testing an investigational medication for heavy menstrual bleeding and pain due to Uterine Fibroids.

Phase N/A

3.77 miles

Learn More »

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. Wake Research Associates is enrolling volunteers in a study testing the effectiveness, and safety of an investigational medication for individuals with NASH and associated bridging fibrosis.

Phase N/A

3.77 miles

Learn More »

It's a disorder, not a decision. If you're one of the many people who has binge eating disorder (B.E.D.), you may feel embarrassment and guilt after eating an excessive amount of food in a set period of time. If you are diagnosed with B.E.D., you may be eligible to participate ...

Phase N/A

3.77 miles

Learn More »

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. If you have a condition called compensated cirrhosis from NASH, Wake Research Associates is enrolling volunteers in a study testing the effectiveness, tolerability and safety of an investigational medication.

Phase N/A

3.77 miles

Learn More »

A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus

The purpose of this study is to assess the effect of canagliflozin relative to placebo on glycated hemoglobin (HbA1c) after 26 weeks of treatment, and to assess the overall safety and tolerability of canagliflozin after 52 weeks of treatment.

Phase

5.21 miles

Learn More »

A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients

This is a randomized (the study medication is assigned by chance), double-blind (neither physician nor participant knows the identity of the assigned treatment), placebo (an inactive substance that is compared with a drug to test whether the drug has a real effect)-controlled, event-driven, multicenter study in patients who are hospitalized ...

Phase

5.9 miles

Learn More »

Absorb IV Randomized Controlled Trial

ABSORB IV: A. Primary Objective: - To evaluate 1-year clinical outcomes of the Absorb BVS compared to XIENCE in the treatment of subjects with ischemic heart disease caused by up to three de novo native coronary artery lesions in a maximum of two epicardial vessels, with a maximum of two ...

Phase N/A

5.9 miles

Learn More »